| Philippe B. Wilson | |
| Workplaces: | University of Bath De Montfort University Nottingham Trent University York St John University National Health Service |
| Alma Mater: | University of Bath |
| Thesis Title: | Towards Isotope Effect Calculations in the Supramolecular Age |
| Thesis Year: | 2016 |
Philippe B. Wilson is a Franco-British healthcare scientist who is Associate Pro Vice-Chancellor for Innovation and Knowledge Exchange, and Professor of One Health at York St John University. Since 2021, he has served as Chief Scientific Officer of NHS Willows Health. His research considers the development of tools and technologies for translational medicine with applications to human, environmental and animal health. He was named by Forbes Magazine in their 2018 30 under 30 Listing for his work in Healthcare and Medicine.
Wilson undertook his secondary education at Churchill Academy and Sixth Form. He was an undergraduate student in chemistry at the University of Bath.[1] He remained at The University of Bath for his doctoral research.[2]
Wilson moved to De Montfort University as an Early Career Academic Fellow in Clinical Chemistry.[3] He became an associate professor at De Montfort University in 2019.[4] There, he worked on nuclear magnetic resonance technologies in point of care applications.
In 2020, Wilson moved to a position as Scientific Director and Head of Conservation of the Rare Breeds Survival Trust in order to support the growing academic activities of the organisation.[5] Same year, he took up the position of chair and Professor of One Health at Nottingham Trent University within the School of Animal, Rural and Environmental Sciences and the Medical Technologies Innovation Facility.
During the COVID-19 pandemic in 2020, Wilson was appointed as Chief Scientific Officer of NHS Willows Health, a National Health Service Primary Care Network. He led the Clinical Trial Unit and achieved First Global Patient In for AstraZeneca's TACKLE monoclonal antibody clinical trial.[6]
Wilson's research now focusses on One Health.[7] He has studied biosensors, including benchtop nuclear magnetic resonance devices and nitrogen-vacancy centers for quantum sensing.[8] He chairs the Royal Society of Biology East Midlands Branch, and is appointed to the UK Genetics of Livestock and Equines Committee within the Department for Food, Environment and Rural Affairs in UK Government,[9] and the Committee on the Toxicity of Chemicals in Food, Consumer Products and the Environment at Public Health England and the Food Standards Agency.[10] In 2022 he was elected to the Comparative Medicine Council of the Royal Society of Medicine.[11] He is a Fellow of the Royal Society of Biology, Fellow of the Royal Society of Medicine and a Fellow of the Linnean Society of London.
In 2024, Wilson was appointed as Associate Pro Vice-Chancellor at York St John University, with responsibility for Innovation and Knowledge Exchange.
Wilson has a background in agriculture from a young age. He was a Trustee of the Poultry Club of Great Britain from 2017 to 2022 where he served in a number of roles including Chairing the Poultry and Eggs Committee of the Charity.[16] He has also served as a Panel B Judge for the Charity.[17] Wilson has published two texts on poultry, The British Poultry Standards 7th Edition, and The Complete Handbook of Poultry, both produced by Wiley.
Self‐Assembled Anion‐Binding Cryptand for the Selective Liquid–Liquid Extraction of Phosphate Anions[18]
Benchtop Low-Frequency 60 MHz NMR Analysis of Urine: A Comparative Metabolomics Investigation[19]
Low-Field, Benchtop NMR Spectroscopy as a Potential Tool for Point-of-Care Diagnostics of Metabolic Conditions: Validation, Protocols and Computational Models[20]
Preliminary demonstration of benchtop NMR metabolic profiling of feline urine: chronic kidney disease as a case study[21]
16 Years of breed management brings substantial improvement in population genetics of the endangered Cleveland Bay Horse[22]